CKD Bio
CKDBio, part of the Chong Kun Dang Group, is Korea’s leading GMP CDMO for Live Biotherapeutic Products (LBPs), the only CDMO in Asia with dedicated anaerobic manufacturing. Our end-to-end services span cell banking, strain characterization, and drug substance/drug product manufacturing, with active development in next-generation modalities including multi-strain consortia and engineered LBPs (e-LBPs). Backed by Chong Kun Dang’s fermentation heritage, CKDBio partners with biotech innovators worldwide to advance microbiome therapies from development to commercial-scale manufacturing.
